4-aminopyridine has been researched along with Hypertrophy, Right Ventricular in 2 studies
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y | 1 |
| Tang, LL | 1 |
| Wei, JK | 1 |
| Xu, XF | 1 |
| Gu, W | 1 |
| Fu, LC | 1 |
| Zhang, LY | 1 |
| Du, LZ | 1 |
| Gillis, AM | 1 |
| Mathison, HJ | 1 |
| Kulisz, E | 1 |
| Lester, WM | 1 |
2 other studies available for 4-aminopyridine and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Decreased Kv1.5 expression in intrauterine growth retardation rats with exaggerated pulmonary hypertension.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Barium Compounds; Cell Hypoxia; Cells, Cultured; Chlorides; | 2013 |
Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anti-Arrhythmia Agents; Hypertrophy, Right Ventricular; | 2000 |